1. Home
  2. CATX vs DMRC Comparison

CATX vs DMRC Comparison

Compare CATX & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATX
  • DMRC
  • Stock Information
  • Founded
  • CATX 1983
  • DMRC 2008
  • Country
  • CATX United States
  • DMRC United States
  • Employees
  • CATX N/A
  • DMRC N/A
  • Industry
  • CATX Medical/Dental Instruments
  • DMRC EDP Services
  • Sector
  • CATX Health Care
  • DMRC Technology
  • Exchange
  • CATX Nasdaq
  • DMRC Nasdaq
  • Market Cap
  • CATX 239.0M
  • DMRC 275.4M
  • IPO Year
  • CATX N/A
  • DMRC N/A
  • Fundamental
  • Price
  • CATX $3.88
  • DMRC $11.78
  • Analyst Decision
  • CATX Strong Buy
  • DMRC Strong Buy
  • Analyst Count
  • CATX 11
  • DMRC 1
  • Target Price
  • CATX $12.90
  • DMRC $30.00
  • AVG Volume (30 Days)
  • CATX 934.1K
  • DMRC 129.1K
  • Earning Date
  • CATX 08-13-2025
  • DMRC 08-14-2025
  • Dividend Yield
  • CATX N/A
  • DMRC N/A
  • EPS Growth
  • CATX N/A
  • DMRC N/A
  • EPS
  • CATX N/A
  • DMRC N/A
  • Revenue
  • CATX $1,471,000.00
  • DMRC $37,848,000.00
  • Revenue This Year
  • CATX N/A
  • DMRC N/A
  • Revenue Next Year
  • CATX N/A
  • DMRC $4.21
  • P/E Ratio
  • CATX N/A
  • DMRC N/A
  • Revenue Growth
  • CATX N/A
  • DMRC 2.44
  • 52 Week Low
  • CATX $1.60
  • DMRC $10.44
  • 52 Week High
  • CATX $16.55
  • DMRC $48.32
  • Technical
  • Relative Strength Index (RSI)
  • CATX 50.75
  • DMRC 36.22
  • Support Level
  • CATX $3.88
  • DMRC $12.05
  • Resistance Level
  • CATX $4.28
  • DMRC $12.97
  • Average True Range (ATR)
  • CATX 0.29
  • DMRC 0.51
  • MACD
  • CATX -0.06
  • DMRC -0.09
  • Stochastic Oscillator
  • CATX 14.61
  • DMRC 0.33

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

Share on Social Networks: